Michael Adena

3.9k total citations · 1 hit paper
57 papers, 2.9k citations indexed

About

Michael Adena is a scholar working on Pathology and Forensic Medicine, General Health Professions and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Michael Adena has authored 57 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pathology and Forensic Medicine, 7 papers in General Health Professions and 7 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Michael Adena's work include Glaucoma and retinal disorders (4 papers), Health and Conflict Studies (4 papers) and Global Health Workforce Issues (4 papers). Michael Adena is often cited by papers focused on Glaucoma and retinal disorders (4 papers), Health and Conflict Studies (4 papers) and Global Health Workforce Issues (4 papers). Michael Adena collaborates with scholars based in Australia, United States and United Kingdom. Michael Adena's co-authors include John G. Morris, M. A. Hely, Glenda M. Halliday, Wayne G.J. Reid, Hugh Gallagher, John A. McKenzie, M. J. Whitten, Elliott Savdie, Deirdre Cobbin and Geoffrey A. Donnan and has published in prestigious journals such as The Lancet, Blood and American Journal of Epidemiology.

In The Last Decade

Michael Adena

56 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Sydney multicenter study of Parkinson's disease: The inevitability of dementia at 20 years

2008 1.6k citations M. A. Hely, Wayne G.J. Reid et al. Movement Disorders profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael Adena Australia	19	1.5k	470	340	336	298	57	2.9k
Pablo Martínez‐Martín Spain	32	1.7k 1.1×	562 1.2×	242 0.7×	277 0.8×	226 0.8×	73	2.7k
Lene Wermuth Denmark	27	903 0.6×	349 0.7×	312 0.9×	160 0.5×	255 0.9×	67	1.9k
Bichun Ouyang United States	25	1.1k 0.7×	320 0.7×	211 0.6×	333 1.0×	272 0.9×	111	2.2k
Reijo J. Marttila Finland	26	1.1k 0.7×	324 0.7×	265 0.8×	194 0.6×	223 0.7×	56	2.7k
A. Reggio Italy	32	943 0.6×	567 1.2×	178 0.5×	120 0.4×	232 0.8×	81	2.9k
Rita Moretti Italy	32	765 0.5×	829 1.8×	539 1.6×	335 1.0×	140 0.5×	118	3.2k
Alessandra Nicoletti Italy	42	2.3k 1.5×	851 1.8×	331 1.0×	427 1.3×	775 2.6×	222	5.6k
John C.M. Brust United States	34	1.2k 0.8×	895 1.9×	466 1.4×	770 2.3×	680 2.3×	113	5.2k
J. Porta‐Etessam Spain	28	1.3k 0.8×	996 2.1×	485 1.4×	172 0.5×	149 0.5×	193	2.9k
Alexander P. Auchus United States	21	422 0.3×	730 1.6×	315 0.9×	213 0.6×	217 0.7×	47	2.3k

Countries citing papers authored by Michael Adena

Since Specialization

Citations

This map shows the geographic impact of Michael Adena's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Adena with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Adena more than expected).

Fields of papers citing papers by Michael Adena

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Adena. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Adena. The network helps show where Michael Adena may publish in the future.

Co-authorship network of co-authors of Michael Adena

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Adena. A scholar is included among the top collaborators of Michael Adena based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Adena. Michael Adena is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

McElroy, Heather, et al.. (2021). Comparative efficacy of lemborexant and other insomnia treatments: a network meta-analysis. Journal of Managed Care & Specialty Pharmacy. 27(9). 1296–1308. 23 indexed citations

Park, Kyu Hyung, Young Joon Jo, Jaeryung Oh, et al.. (2019). Healthcare Utilization and Treatment Patterns in Diabetic Macular Edema in Korea: a Retrospective Chart Review. Journal of Korean Medical Science. 34(15). e118–e118. 8 indexed citations

Stollenwerk, Björn, Sergio Iannazzo, Ron Akehurst, et al.. (2018). A Decision-Analytic Model to Assess the Cost-Effectiveness of Etelcalcetide vs. Cinacalcet. PharmacoEconomics. 36(5). 603–612. 7 indexed citations

Sheu, Shwu‐Jiuan, Cheng‐Kuo Cheng, Hsi‐Kung Kuo, et al.. (2018). Treatment patterns in diabetic macular edema in Taiwan: a retrospective chart review. Clinical ophthalmology. Volume 12. 2189–2198. 6 indexed citations

Adena, Michael, et al.. (2018). Cost-Effectiveness of Ivabradine in the Treatment of Chronic Heart Failure. Heart Lung and Circulation. 28(3). 414–422. 12 indexed citations

Stollenwerk, Björn, Sergio Iannazzo, Ron Akehurst, et al.. (2016). Assessing The Cost-Utility of Etelcalcetide: A Markov Model. Value in Health. 19(7). A519–A519. 2 indexed citations

Adena, Michael, et al.. (2014). Modelling the Cost Effectiveness of Rituximab in Chronic Lymphocytic Leukaemia in First-Line Therapy and Following Relapse. PharmacoEconomics. 32(2). 193–207. 19 indexed citations

Liew, Danny, et al.. (2013). Cost-Effectiveness of 12-Month Treatment With Ticagrelor Compared With Clopidogrel in the Management of Acute Coronary Syndromes. Clinical Therapeutics. 35(8). 1110–1117.e9. 16 indexed citations

Kowalski, Jeanne, et al.. (2011). PSS13 INCREMENTAL COST-UTILITY ANALYSIS OF DEXAMETHASONE INTRAVITREAL IMPLANT FOR THE TREATMENT OF MACULAR EDEMA FOLLOWING RETINAL VEIN OCCLUSION. Value in Health. 14(3). A55–A55. 1 indexed citations

10.

Hely, M. A., Wayne G.J. Reid, Michael Adena, Glenda M. Halliday, & John G. Morris. (2008). The Sydney multicenter study of Parkinson's disease: The inevitability of dementia at 20 years. Movement Disorders. 23(6). 837–844. 1614 indexed citations breakdown →

11.

Adena, Michael, et al.. (2008). Use of simulation to compare the performance of minimization with stratified blocked randomization. Pharmaceutical Statistics. 8(4). 264–278. 14 indexed citations

12.

Bodsworth, Neil, Mark Bloch, Anna McNulty, et al.. (2008). 2-day versus 5-day famciclovir as treatment of recurrences of genital herpes: results of the FaST study. Sexual Health. 5(3). 219–219. 17 indexed citations

13.

Damianovich, Dragan, Michael Adena, & Niall C. Tebbutt. (2007). Treatment of 5-fluorouracil refractory metastatic colorectal cancer: an Australian population-based analysis. British Journal of Cancer. 96(4). 546–550. 7 indexed citations

14.

Prince, H. Miles, et al.. (2007). Efficacy of single‐agent bortezomib vs. single‐agent thalidomide in patients with relapsed or refractory multiple myeloma: a systematic comparison. European Journal Of Haematology. 79(2). 93–99. 10 indexed citations

15.

Jones, Judith A., John Humphreys, & Michael Adena. (2004). Doctors' perspectives on the viability of rural practice. Rural and Remote Health. 4(2). 305–305. 8 indexed citations

16.

Davies, Alison, Michael Adena, Nicholas A Keks, et al.. (1998). Risperidone versus haloperidol: I. meta-analysis of efficacy and safety. Clinical Therapeutics. 20(1). 58–71. 51 indexed citations

17.

Campbell, John, et al.. (1990). Is Mucaine an Appropriate Medication for the Relief of Heartburn during Pregnancy?. Asia-Oceania Journal of Obstetrics and Gynaecology. 16(4). 357–362. 7 indexed citations

18.

Donnan, Geoffrey A., et al.. (1989). SMOKING AS A RISK FACTOR FOR CEREBRAL ISCHAEMIA. The Lancet. 334(8664). 643–647. 116 indexed citations

19.

Adena, Michael. (1989). The health of Australian veterans. The Medical Journal of Australia. 150(7). 356–357. 2 indexed citations

20.

Guy, P. L., J. L. Dale, Michael Adena, & Adrian J. Gibbs. (1984). A taxonomic study of the host ranges of tymoviruses. Plant Pathology. 33(3). 337–346. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact